|
Name |
[4-Methoxy-3-methylsulfanyl-6-(2-pyridyl)-2-pyridyl]methanol
|
Molecular Formula | C13H14N2O2S | |
IUPAC Name* |
(4-methoxy-3-methylsulfanyl-6-pyridin-2-ylpyridin-2-yl)methanol
|
|
SMILES |
COC1=CC(=NC(=C1SC)CO)C2=CC=CC=N2
|
|
InChI |
InChI=1S/C13H14N2O2S/c1-17-12-7-10(9-5-3-4-6-14-9)15-11(8-16)13(12)18-2/h3-7,16H,8H2,1-2H3
|
|
InChIKey |
MKEKAXKNTUEPCM-UHFFFAOYSA-N
|
|
Synonyms |
[4-methoxy-3-methylsulfanyl-6-(2-pyridyl)-2-pyridyl]methanol; SCHEMBL2625183; SF2738C; DTXSID101220193; SF-2738C; SF2738; 4-Methoxy-5-(methylthio)[2,2'-bipyridine]-6-methanol; (4-methoxy-3-methylsulfanyl-6-pyridin-2-ylpyridin-2-yl)methanol; 161504-74-1
|
|
CAS | 161504-74-1 | |
PubChem CID | 10084065 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 262.33 | ALogp: | 1.1 |
HBD: | 1 | HBA: | 5 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 80.5 | Aromatic Rings: | 2 |
Heavy Atoms: | 18 | QED Weighted: | 0.858 |
Caco-2 Permeability: | -4.672 | MDCK Permeability: | 0.00001640 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.001 |
30% Bioavailability (F30%): | 0.058 |
Blood-Brain-Barrier Penetration (BBB): | 0.893 | Plasma Protein Binding (PPB): | 87.29% |
Volume Distribution (VD): | 0.759 | Fu: | 10.45% |
CYP1A2-inhibitor: | 0.949 | CYP1A2-substrate: | 0.725 |
CYP2C19-inhibitor: | 0.124 | CYP2C19-substrate: | 0.699 |
CYP2C9-inhibitor: | 0.033 | CYP2C9-substrate: | 0.813 |
CYP2D6-inhibitor: | 0.009 | CYP2D6-substrate: | 0.672 |
CYP3A4-inhibitor: | 0.043 | CYP3A4-substrate: | 0.432 |
Clearance (CL): | 8.487 | Half-life (T1/2): | 0.85 |
hERG Blockers: | 0.017 | Human Hepatotoxicity (H-HT): | 0.192 |
Drug-inuced Liver Injury (DILI): | 0.966 | AMES Toxicity: | 0.456 |
Rat Oral Acute Toxicity: | 0.198 | Maximum Recommended Daily Dose: | 0.207 |
Skin Sensitization: | 0.167 | Carcinogencity: | 0.437 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.678 |
Respiratory Toxicity: | 0.924 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004907 | 0.705 | D0L5KU | 0.297 | ||||
ENC004908 | 0.618 | D0E3FD | 0.293 | ||||
ENC001994 | 0.529 | D0KL4J | 0.268 | ||||
ENC003523 | 0.529 | D0T6XX | 0.265 | ||||
ENC001367 | 0.313 | D0T1LK | 0.265 | ||||
ENC004659 | 0.310 | D06CTE | 0.259 | ||||
ENC000033 | 0.288 | D06YYD | 0.247 | ||||
ENC001375 | 0.278 | D06QKV | 0.247 | ||||
ENC002427 | 0.275 | D0NJ3V | 0.245 | ||||
ENC002077 | 0.275 | D06AEB | 0.243 |